Condition
Fistula-in-ano
Total Trials
6
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Recruiting2
Unknown1
Completed1
Suspended1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07021742RecruitingPrimary
BioHealx® Anal Fistula Device Post Market Surveillance Study
NCT07579715Not ApplicableCompleted
Comparison Of Surgical Outcomes Between Ligation Of Intersphincteric Fistula Tract And Fistulotomy With Seton In Perianal Fistula
NCT07098715Not ApplicableEnrolling By InvitationPrimary
A Study Of Cryptoglandular Fistula-in-ano And Associated Non-healing Draining Wounds With Kerecis SurgiClose
NCT06386835Not ApplicableRecruitingPrimary
Collagen Paste vs Mucosal Advancement Flap for FIA
NCT03017898Not ApplicableSuspendedPrimary
Treatment of Anal Fistula With Lasercoagulation
NCT02579330Not ApplicableUnknownPrimary
Trial on Use of Coloshield in Transanal and Anal Surgery
Showing all 6 trials